ANVS
Annovis Bio, Inc.
NYSE · Healthcare · Biotechnology · US
$1.39
+0.72%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-26.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | Hoffman Michael B · director | Purchase | 2,562 | $1.75 |
| May 21, 2026 | Hoffman Michael B · director | Purchase | 54,933 | $1.90 |
| May 21, 2026 | Hoffman Michael B · director | Purchase | 18,849 | $1.80 |
| Apr 3, 2026 | Hoffman Michael B · director | Purchase | 713,800 | $2.10 |
| Dec 8, 2025 | Hoffman Michael B · director | Purchase | 30,000 | $4.34 |
| Dec 8, 2025 | Hoffman Michael B · director | Purchase | 15,000 | $4.24 |
| Nov 25, 2025 | Hoffman Michael B · director | Purchase | 9,200 | $3.85 |
| Nov 25, 2025 | Hoffman Michael B · director | Purchase | 415 | $4.14 |
| Nov 25, 2025 | Hoffman Michael B · director | Purchase | 28,096 | $4.15 |
| Nov 25, 2025 | Hoffman Michael B · director | Purchase | 1,489 | $4.13 |
| Nov 21, 2025 | Hoffman Michael B · director | Purchase | 10,000 | $3.50 |
| Nov 18, 2025 | Hoffman Michael B · director | Purchase | 15,000 | $2.11 |
| Nov 12, 2025 | Bruck Claudine · director | M-Exempt | 7,142 | $0.14 |
| Nov 12, 2025 | Maccecchini Maria-Luisa · director, officer: President & CEO | Purchase | 97,561 | $2.05 |
| Nov 12, 2025 | Hoffman Michael B · director | Purchase | 975,610 | $2.05 |
| Sep 3, 2025 | Hoffman Michael B · director | A-Award | 5,000 | $2.30 |
| Aug 20, 2025 | Hoffman Michael B · director | A-Award | 6,717 | $2.60 |
| Aug 20, 2025 | Hoffman Michael B · director | A-Award | 1,100 | $2.57 |
| Aug 20, 2025 | Hoffman Michael B · director | A-Award | 5,545 | $2.58 |
| Aug 20, 2025 | Hoffman Michael B · director | A-Award | 5,283 | $2.59 |
| Jun 18, 2025 | Walsh Andrew · officer: Vice President, Finance | A-Award | 500 | $2.90 |
| Jun 16, 2025 | Hoffman Michael B · director | A-Award | 1 | $2.83 |
| Jun 16, 2025 | Hoffman Michael B · director | A-Award | 25,000 | $2.80 |
| Jun 11, 2025 | McCarthy Reid · director | A-Award | 2,000 | $2.95 |
| Jun 5, 2025 | Maccecchini Maria-Luisa · director, officer: President & CEO | A-Award | 46,000 | $3.37 |
| Jun 2, 2025 | Hoffman Michael B · director | A-Award | 5,000 | $2.43 |
| Jul 3, 2024 | McCarthy Reid · director | A-Award | 29,600 | $6.07 |
| Jul 3, 2024 | White Mark K. · director | A-Award | 26,200 | $6.07 |
| Jul 3, 2024 | White Mark K. · director | A-Award | 20,000 | $5.27 |
| Jul 3, 2024 | White Mark K. · director | A-Award | 2,146 | $7.39 |
Institutional positioning
13F filings over the trailing two quarters
New 29Increased 34Reduced 19Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Empery Asset Management, LP | New Position | 2,401,476 | Aug 11, 2026 |
| MARSHALL WACE, LLP | Increased | 1,842,339 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,647,322 | Aug 13, 2026 |
| TUDOR INVESTMENT CORP ET AL | New Position | 1,357,134 | Aug 14, 2026 |
| MARSHALL WACE, LLP | Increased | 1,187,499 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1,002,200 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 872,381 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 627,659 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 579,571 | Aug 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 562,404 | Aug 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 541,036 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 506,482 | Sep 2, 2026 |
| Caption Management, LLC | New Position | 474,900 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 347,600 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 283,817 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 21, 2026